Acrolein induces selective protein carbonylation in synaptosomes

Neuroscience

Volumn 147, Issue 3, 2007, Pages 674-679

  Mello, C F ^a,b   Sultana, R ^a   Piroddi, M ^a,c   Cai, J ^d   Pierce, W M ^d   Klein, J B ^e   Butterfield, D A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; BETA ACTIN; ELONGATION FACTOR; TROPOMYOSIN; TROPOMYOSIN 3 GAMMA ISOFORM 2; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GERBIL; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN FUNCTION; PROTEOMICS; SYNAPTOSOME; TWO DIMENSIONAL ELECTROPHORESIS;

ACROLEIN; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GERBILLINAE; MALE; MASS SPECTROMETRY; PROTEIN CARBONYLATION; SYNAPTOSOMES;

EID: 34250834295     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.04.003     Document Type: Article

References (46)

1. Adams Jr. J.D., and Klaidman L.K. Acrolein-induced oxygen radical formation. Free Radic Biol Med 15 (1993) 187-193
2. Aksenov M.Y., Aksenova M.V., Butterfield D.A., Geddes J.W., and Markesbery W.R. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103 (2001) 373-383
3. Beck K.A., and Nelson W.J. The spectrin-based membrane skeleton as a membrane protein-sorting machine. Am J Physiol 270 (1996) C1263-C1270
4. Berlett B.S., and Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272 (1997) 20313-20316
5. Boyd-Kimball D., Castegna A., Sultana R., Poon H.F., Petroze R., Lynn B.C., Klein J.B., and Butterfield D.A. Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease. Brain Res 1044 (2005) 206-215
6. Butterfield D.A., Boyd-Kimball D., and Castegna A. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration. J Neurochem 86 (2003) 1313-1327
7. Butterfield D.A., Castegna A., Lauderback C.M., and Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23 (2002) 655-664
8. Butterfield D.A., and Stadtman E.R. Protein oxidation processes in aging brain. Adv Cell Aging Gerontol 2 (1997) 161-191
9. Calingasan N.Y., Uchida K., and Gibson G.E. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72 (1999) 751-756
10. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Markesbery W.R., and Butterfield D.A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33 (2002) 562-571
11. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Markesbery W.R., and Butterfield D.A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82 (2002) 1524-1532
12. Comporti M., Maellaro E., Del Bello B., and Casini A.F. Glutathione depletion: its effects on other antioxidant systems and hepatocellular damage. Xenobiotica 21 (1991) 1067-1076
13. Drake S.K., Bourdon E., Wehr N.B., Levine R.L., Backlund P.S., Yergey A.L., and Rouault T.A. Numerous proteins in mammalian cells are prone to iron-dependent oxidation and proteasomal degradation. Dev Neurosci 24 (2002) 114-124
14. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11 (1991) 81-128
15. Gilman S.C., Bonner M.J., and Pellmar T.C. Effect of oxidative stress on excitatory amino acid release by cerebral cortical synaptosomes. Free Radic Biol Med 15 (1993) 671-675
16. Gray E.G., and Whittaker V.P. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 96 (1962) 79-88
17. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine (1999), Oxford University Press, Oxford
18. Halpain S. Actin in a supporting role. Nat Neurosci 6 (2003) 101-102
19. Hensley K., Carney J., Hall N., Shaw W., and Butterfield D.A. Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure. Free Radic Biol Med 17 (1994) 321-331
20. Horton N.D., Mamiya B.M., and Kehrer J.P. Relationships between cell density, glutathione and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. Toxicology 122 (1997) 111-122
21. Kehrer J.P., and Biswal S.S. The molecular effects of acrolein. Toxicol Sci 57 (2000) 6-15
22. Lemasters J.J., and Holmuhamedov E. Voltage-dependent anion channel (VDAC) as mitochondrial governator: thinking outside the box. Biochim Biophys Acta 1762 (2006) 181-190
23. Lovell M.A., Xie C., and Markesbery W.R. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic Biol Med 29 (2000) 714-720
24. Lovell M.A., Xie C., and Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22 (2001) 187-194
25. Luo J., Uchida K., and Shi R. Accumulation of acrolein-protein adducts after traumatic spinal cord injury. Neurochem Res 30 (2005) 291-295
26. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., and Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 68 (1997) 255-264
27. Markesbery W.R., and Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19 (1998) 33-36
28. Montine T.J., Neely M.D., Quinn J.F., Beal M.F., Markesbery W.R., Roberts L.J., and Morrow J.D. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med 33 (2002) 620-626
29. Patel J.M., and Block E.R. Acrolein-induced injury to cultured pulmonary artery endothelial cells. Toxicol Appl Pharmacol 122 (1993) 46-53
30. Pocernich C.B., and Butterfield D.A. Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res 5 (2003) 515-520
31. Pocernich C.B., Cardin A.L., Racine C.L., Lauderback C.M., and Butterfield D.A. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem Int 39 (2001) 141-149
32. Seidler N.W., and Squire T.J. Abeta-polyacrolein aggregates: novel mechanism of plastic formation in senile plaques. Biochem Biophys Res Commun 335 (2005) 501-504
33. Seidler N.W., and Yeargans G.S. Albumin-bound polyacrolein: implications for Alzheimer's disease. Biochem Biophys Res Commun 320 (2004) 213-217
34. Shimizu S., Narita M., and Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399 (1999) 483-487
35. Shin J.H., London J., Le Pecheur M., Hoger H., Pollak D., and Lubec G. Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1. Free Radic Biol Med 37 (2004) 643-653
36. Shoshan-Barmatz V., and Gincel D. The voltage-dependent anion channel: characterization, modulation, and role in mitochondrial function in cell life and death. Cell Biochem Biophys 39 (2003) 279-292
37. Sultana R., Boyd-Kimball D., Poon H.F., Cai J., Pierce W.M., Klein J.B., Markesbery W.R., Zhou X.Z., Lu K.P., and Butterfield D.A. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol Aging 27 (2006) 918-925
38. Sultana R., Perluigi M., and Butterfield D.A. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta (1-42). J Chromatogr B Analyt Technol Biomed Life Sci 833 (2006) 3-11
39. Sultana R., Poon H.F., Cai J., Pierce W.M., Merchant M., Klein J.B., Markesbery W.R., and Butterfield D.A. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22 (2006) 76-87
40. Suzuki D., and Miyata T. Carbonyl stress in the pathogenesis of diabetic nephropathy. Intern Med 38 (1999) 309-314
41. Takano K., Ogura M., Yoneda Y., and Nakamura Y. Oxidative metabolites are involved in polyamine-induced microglial cell death. Neuroscience 134 (2005) 1123-1131
42. Tsujimoto Y., Nakagawa T., and Shimizu S. Mitochondrial membrane permeability transition and cell death. Biochim Biophys Acta 1757 (2006) 1297-1300
43. Tsujimoto Y., and Shimizu S. The voltage-dependent anion channel: an essential player in apoptosis. Biochimie 84 (2002) 187-193
44. Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 9 (1999) 109-113
45. Uchida K., Kanematsu M., Sakai K., Matsuda T., Hattori N., Mizuno Y., Suzuki D., Miyata T., Noguchi N., Niki E., and Osawa T. Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci U S A 95 (1998) 4882-4887
46. Yang X., Wu X., Choi Y.E., Kern J.C., and Kehrer J.P. Effect of acrolein and glutathione depleting agents on thioredoxin. Toxicology 204 (2004) 209-218